Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Epigenetics in cancer genesis

Dr Manel Esteller – Instituto de Investigación Biomédica de Bellvitge...

Epigenetics in cancer genesis ( Dr Manel Esteller – Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain )

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel

What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )

Expert discussion on current experience with monoclonal antibodies in multiple...

Prof Antonio Palumbo and Prof Philippe Moreau

Expert discussion on current experience with monoclonal antibodies in multiple myeloma ( Prof Antonio Palumbo and Prof Philippe Moreau )

ECC 2015: Editor's highlights

Prof Gordon McVie - ecancer Managing Editor

ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )

ecancermedicalscience editor's choice for September 2015

Prof Gordon McVie - ecancer Managing Editor

ecancermedicalscience editor's choice for September 2015 ( Prof Gordon McVie - ecancer Managing Editor )

First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA

First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA )

Is it possible to develop cancer drugs at a lower cost?

Prof Andrew Hill - University of Liverpool, Liverpool, UK

Is it possible to develop cancer drugs at a lower cost? ( Prof Andrew Hill - University of Liverpool, Liverpool, UK )

Expanding access to crizotinib using a biomarker-driven approach

Prof Gilles Vassal - University Paris-Sud, Orsay, France

Expanding access to crizotinib using a biomarker-driven approach ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )

Multi-peptide vaccine for kidney cancer fails to improve survival

Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA

Multi-peptide vaccine for kidney cancer fails to improve survival ( Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA )

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )

Survival in all gastrointestinal cancers improved by aspirin post diagnosis

Ms Martine Frouws - Leiden University Medical Center, Leiden, The Netherlands

Survival in all gastrointestinal cancers improved by aspirin post diagnosis ( Ms Martine Frouws - Leiden University Medical Center, Leiden, The Netherlands )

Add panitumumab or bevacizumab to improve first-line metastatic colorectal...

Dr Fernardo Rivera - Hospital Universitario Marques de Valdecilla, Santander...

Add panitumumab or bevacizumab to improve first-line metastatic colorectal cancer therapy? ( Dr Fernardo Rivera - Hospital Universitario Marques de Valdecilla, Santander, Spain )

More from ecancer